4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-21-066005
CHIEF FINANCIAL OFFICER bought 955 shares at an average $35.26 ($33,676)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pizzie Nick CHIEF FINANCIAL OFFICER | 2021-11-18 | Purchase | +527 | $35.50 | $18,709 | 41,789 | D |
| Pizzie Nick CHIEF FINANCIAL OFFICER | 2021-11-18 | Purchase | +141 | $35.43 | $4,996 | 201 | I |
| Pizzie Nick CHIEF FINANCIAL OFFICER | 2021-11-18 | Purchase | +145 | $34.30 | $4,974 | 145 | I |
| Pizzie Nick CHIEF FINANCIAL OFFICER | 2021-11-18 | Purchase | +142 | $35.20 | $4,998 | 142 | I |
| Open-market purchases · 955 sh · avg $35.26 · $33,676 | |||||||
Loading xslF345X03/doc4.xml…